Improving research quality: the view from the UK Reproducibility Network institutional leads for research improvement.

FAIR data Research openness Research reproducibility Research transparency

Journal

BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768

Informations de publication

Date de publication:
20 Dec 2021
Historique:
received: 03 11 2021
accepted: 09 12 2021
entrez: 21 12 2021
pubmed: 22 12 2021
medline: 24 12 2021
Statut: epublish

Résumé

The adoption and incentivisation of open and transparent research practices is critical in addressing issues around research reproducibility and research integrity. These practices will require training and funding. Individuals need to be incentivised to adopt open and transparent research practices (e.g., added as desirable criteria in hiring, probation, and promotion decisions, recognition that funded research should be conducted openly and transparently, the importance of publishers mandating the publication of research workflows and appropriately curated data associated with each research output). Similarly, institutions need to be incentivised to encourage the adoption of open and transparent practices by researchers. Research quality should be prioritised over research quantity. As research transparency will look different for different disciplines, there can be no one-size-fits-all approach. An outward looking and joined up UK research strategy is needed that places openness and transparency at the heart of research activity. This should involve key stakeholders (institutions, research organisations, funders, publishers, and Government) and crucially should be focused on action. Failure to do this will have negative consequences not just for UK research, but also for our ability to innovate and subsequently commercialise UK-led discovery.

Identifiants

pubmed: 34930427
doi: 10.1186/s13104-021-05883-3
pii: 10.1186/s13104-021-05883-3
pmc: PMC8686561
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

458

Informations de copyright

© 2021. The Author(s).

Références

Sci Data. 2016 Mar 15;3:160018
pubmed: 26978244
PLoS Biol. 2016 May 12;14(5):e1002460
pubmed: 27171138
BMJ. 1994 Jan 29;308(6924):283-4
pubmed: 8124111
PLoS One. 2021 Jun 21;16(6):e0251194
pubmed: 34153038
F1000Res. 2021 Mar 30;10:253
pubmed: 34367614
PLoS Biol. 2021 Nov 10;19(11):e3001461
pubmed: 34758016

Auteurs

Andrew J Stewart (AJ)

University of Manchester, Manchester, UK. andrew.j.stewart@manchester.ac.uk.

Emily K Farran (EK)

University of Surrey, Surrey, UK.

Malcolm Macleod (M)

University of Edinburgh, Edinburgh, UK.

Marcus Munafò (M)

University of Bristol, Bristol, UK.

Phil Newton (P)

University of Reading, Reading, UK.

David R Shanks (DR)

University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH